Overview

Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
To assess the long term safety, tolerability and efficacy of fesoterodine in patients with OAB.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Fesoterodine